1. Home
  2. MORN vs BMRN Comparison

MORN vs BMRN Comparison

Compare MORN & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morningstar Inc.

MORN

Morningstar Inc.

N/A

Current Price

$183.71

Market Cap

8.8B

Sector

Finance

ML Signal

N/A

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

N/A

Current Price

$61.32

Market Cap

10.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MORN
BMRN
Founded
1984
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
10.0B
IPO Year
2004
1999

Fundamental Metrics

Financial Performance
Metric
MORN
BMRN
Price
$183.71
$61.32
Analyst Decision
Strong Buy
Buy
Analyst Count
2
16
Target Price
$256.50
$87.38
AVG Volume (30 Days)
708.1K
2.3M
Earning Date
05-18-2026
05-21-2026
Dividend Yield
1.05%
N/A
EPS Growth
3.38
N/A
EPS
8.87
1.80
Revenue
$2,445,500,000.00
$1,313,646,000.00
Revenue This Year
$9.02
$13.34
Revenue Next Year
$6.34
$11.42
P/E Ratio
$21.37
$34.15
Revenue Growth
7.49
17.62
52 Week Low
$149.08
$50.76
52 Week High
$316.71
$73.18

Technical Indicators

Market Signals
Indicator
MORN
BMRN
Relative Strength Index (RSI) 53.20 55.56
Support Level $149.08 $56.08
Resistance Level $219.68 $64.71
Average True Range (ATR) 6.07 2.36
MACD 3.72 -0.16
Stochastic Oscillator 79.30 37.30

Price Performance

Historical Comparison
MORN
BMRN

About MORN Morningstar Inc.

Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: